UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

The Betelgeuse Project. III. Merger Characteristics

The Astrophysical journal, 2020-12, Vol.905 (2), p.128

2020

Volltextzugriff (PDF)

Fleet behavior is responsive to a large-scale environmental disturbance: Hypoxia effects on the spatial dynamics of the northern Gulf of Mexico shrimp fishery

PloS one, 2017-08, Vol.12 (8), p.e0183032-e0183032

2017

Volltextzugriff (PDF)

The Betelgeuse Project II: asteroseismology

Monthly notices of the Royal Astronomical Society, 2018-09, Vol.479 (1), p.251-261

2018

Volltextzugriff (PDF)

Seafood prices reveal impacts of a major ecological disturbance

Proceedings of the National Academy of Sciences - PNAS, 2017-02, Vol.114 (7), p.1512-1517

2017

Volltextzugriff (PDF)

Histrelin implantation in the pediatric population: A 10-year institutional experience

Journal of pediatric surgery, 2019-07, Vol.54 (7), p.1457-1461

2019

Volltextzugriff (PDF)

Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study

PloS one, 2022-05, Vol.17 (5), p.e0268284

2022

Volltextzugriff (PDF)

The Betelgeuse Project: constraints from rotation

Monthly notices of the Royal Astronomical Society, 2017-03, Vol.465 (3), p.2654-2654

2017

Volltextzugriff (PDF)

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354

Bioorganic & medicinal chemistry letters, 2014-10, Vol.24 (19), p.4708-4713

2014

Volltextzugriff (PDF)

Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

ACS medicinal chemistry letters, 2017-02, Vol.8 (2), p.233-238

2017

Volltextzugriff (PDF)

Acute flaccid myelitis: cause, diagnosis, and management

The Lancet (British edition), 2021-01, Vol.397 (10271), p.334-346

2021

Volltextzugriff (PDF)

Discovery of (S)‑2-Cyclopentyl‑N‑((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro‑1H‑pyrrido[3,4‑b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)

Journal of medicinal chemistry, 2014-12, Vol.57 (23), p.10192-10197

2014

Volltextzugriff (PDF)

Total synthesis of natural (−)- and unnatural (+)-Melearoride A

Tetrahedron letters, 2019-03, Vol.60 (10), p.743-745

2019

Volltextzugriff (PDF)

A Novel M 1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity

ACS chemical neuroscience, 2018-09, Vol.9 (9), p.2274-2285

2018

Volltextzugriff (PDF)

Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione Core

Journal of medicinal chemistry, 2017-02, Vol.60 (4), p.1611-1616

2017

Volltextzugriff (PDF)

The discovery of VU0486846: steep SAR from a series of M 1 PAMs based on a novel benzomorpholine core

Bioorganic & medicinal chemistry letters, 2018-07, Vol.28 (12), p.2175

2018

Volltextzugriff (PDF)

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets

Archives of pathology & laboratory medicine (1976), 2013-01, Vol.137 (1), p.32-40

2013

Volltextzugriff (PDF)

The discovery of VU0486846: steep SAR from a series of M1 PAMs based on a novel benzomorpholine core

Bioorganic & medicinal chemistry letters, 2018-07, Vol.28 (12), p.2175-2179

2018

Volltextzugriff (PDF)

Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes

Bioorganic & medicinal chemistry letters, 2016-09, Vol.26 (18), p.4487-4491

2016

Volltextzugriff (PDF)

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256

ACS chemical neuroscience, 2016-12, Vol.7 (12), p.1706-1716

2016

Volltextzugriff (PDF)

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M 1 PAM VU6004256

ACS chemical neuroscience, 2016-12, Vol.7 (12), p.1706-1716

2016

Volltextzugriff (PDF)

Optimization of M 4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2296-2301

2017

Volltextzugriff (PDF)

Optimization of M4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2296-2301

2017

Volltextzugriff (PDF)

Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs

ACS chemical neuroscience, 2017-04, Vol.8 (4), p.866-883

2017

Volltextzugriff (PDF)

Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds

Pharmacotherapy, 2023-05, Vol.43 (5), p.381-390

2023

Volltextzugriff (PDF)

Discovery of VU0467485/AZ13713945: An M 4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

ACS medicinal chemistry letters, 2017-02, Vol.8 (2), p.233-238

2017

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Betelgeuse Project. III. Merger Characteristics

Fleet behavior is responsive to a large-scale environmental disturbance: Hypoxia effects on the spatial dynamics of the northern Gulf of Mexico shrimp fishery

The Betelgeuse Project II: asteroseismology

Seafood prices reveal impacts of a major ecological disturbance

Histrelin implantation in the pediatric population: A 10-year institutional experience

Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study

The Betelgeuse Project: constraints from rotation

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354

Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

Acute flaccid myelitis: cause, diagnosis, and management

Discovery of (S)‑2-Cyclopentyl‑N‑((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro‑1H‑pyrrido[3,4‑b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)

Total synthesis of natural (−)- and unnatural (+)-Melearoride A

A Novel M 1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity

Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione Core

The discovery of VU0486846: steep SAR from a series of M 1 PAMs based on a novel benzomorpholine core

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets

The discovery of VU0486846: steep SAR from a series of M1 PAMs based on a novel benzomorpholine core

Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256

Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M 1 PAM VU6004256

Optimization of M 4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

Optimization of M4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs

Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds

Discovery of VU0467485/AZ13713945: An M 4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

Suchergebnisse filtern